What Happens to Frailty in the First Year After Lung Transplantation?


Journal

Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240

Informations de publication

Date de publication:
Jul 2024
Historique:
revised: 23 05 2024
received: 02 07 2023
accepted: 13 06 2024
medline: 18 7 2024
pubmed: 18 7 2024
entrez: 18 7 2024
Statut: ppublish

Résumé

Frailty is prevalent in lung transplant (LTx) candidates, but the impact and subsequent frailty trajectory is unclear. This study aimed to investigate frailty over the first year after LTx. Post-LTx recipients completed a thrice weekly 12-week directly supervised exercise rehabilitation program. Edmonton Frail Scale (EFS) was used to assess frailty. Primary outcome was 6-Minute Walk Distance (6MWD) measured at pre-LTx, prerehabilitation, postrehabilitation, and 1 year post-LTx. 106 of 139 recruited participants underwent LTx: mean age 58 years, 48% male, 52% with chronic obstructive pulmonary disease. Mean (± SD) frailty scores pre-LTx and 1 year post-LTx were 5.54 ± 2.4 and 3.28 ±1.5. Mean 6MWD improved significantly for all: prerehabilitation 326 m (SD 116), versus postrehabilitation 523 m (SD 101) (p < 0.001) versus 1 year 512 m (SD 120) (p < 0.001). There were significant differences between an EFS > 7 (frail) and EFS ≤ 7 (not frail) for 6MWD, grip strength (GS), anxiety, and depression. Postrehabilitation, there were no significant differences in 6MWD, GS, anxiety, or depression while comparing EFS > 7 versus ≤ 7. At 1 year, there was a significant difference in depression but not 6MWD, GS, or anxiety between those EFS ≤ 7 and > 7 (p = 0.017). Participants in a structured post-LTx rehabilitation program improved in functional exercise capacity (6MWD), GS, depression, and anxiety. For frail participants exercise capacity, depression, anxiety, and GS were well managed in rehabilitation with no significant differences between those who were not frail. Pre-LTx frailty may be reversible post-LTx and should not be an absolute contraindication to LTx.

Sections du résumé

BACKGROUND BACKGROUND
Frailty is prevalent in lung transplant (LTx) candidates, but the impact and subsequent frailty trajectory is unclear. This study aimed to investigate frailty over the first year after LTx.
METHOD METHODS
Post-LTx recipients completed a thrice weekly 12-week directly supervised exercise rehabilitation program. Edmonton Frail Scale (EFS) was used to assess frailty. Primary outcome was 6-Minute Walk Distance (6MWD) measured at pre-LTx, prerehabilitation, postrehabilitation, and 1 year post-LTx.
RESULTS RESULTS
106 of 139 recruited participants underwent LTx: mean age 58 years, 48% male, 52% with chronic obstructive pulmonary disease. Mean (± SD) frailty scores pre-LTx and 1 year post-LTx were 5.54 ± 2.4 and 3.28 ±1.5. Mean 6MWD improved significantly for all: prerehabilitation 326 m (SD 116), versus postrehabilitation 523 m (SD 101) (p < 0.001) versus 1 year 512 m (SD 120) (p < 0.001). There were significant differences between an EFS > 7 (frail) and EFS ≤ 7 (not frail) for 6MWD, grip strength (GS), anxiety, and depression. Postrehabilitation, there were no significant differences in 6MWD, GS, anxiety, or depression while comparing EFS > 7 versus ≤ 7. At 1 year, there was a significant difference in depression but not 6MWD, GS, or anxiety between those EFS ≤ 7 and > 7 (p = 0.017).
CONCLUSION CONCLUSIONS
Participants in a structured post-LTx rehabilitation program improved in functional exercise capacity (6MWD), GS, depression, and anxiety. For frail participants exercise capacity, depression, anxiety, and GS were well managed in rehabilitation with no significant differences between those who were not frail. Pre-LTx frailty may be reversible post-LTx and should not be an absolute contraindication to LTx.

Identifiants

pubmed: 39023090
doi: 10.1111/ctr.15393
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e15393

Subventions

Organisme : Small Projects Grants Alfred Health Research Unit

Informations de copyright

© 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

K. R. Balsara, A. S. Krupnick, J. M. Bell, et al., “A Single‐Center Experience of 1500 Lung Transplant Patients,” Journal of Thoracic and Cardiovascular Surgery 156, no. 2 (2018): 894–905.e3.
D. Weill, C. Benden, P. A. Corris, et al., “A Consensus Document for the Selection of Lung Transplant Candidates: 2014–An Update From the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation,” Journal of Heart & Lung Transplantation 34, no. 1 (2015): 1–15.
L. E. Leard, A. M. Holm, M. Valapour, et al., “Consensus Document for the Selection of Lung Transplant Candidates: An Update From the International Society for Heart and Lung Transplantation,” The Journal of Heart and Lung Transplantation 40, no. 11 (2021): 1349–1379, https://doi.org/10.1016/j.healun.2021.07.005.
L. P. Fried, C. M. Tangen, J. Walston, et al., “Frailty in Older Adults: Evidence for a Phenotype,” Journals of Gerontology Series A‐Biological Sciences & Medical Sciences 56, no. 3 (2001): M146–M156.
L. P. Fried, Q. L. Xue, A. R. Cappola, et al., “Nonlinear Multisystem Physiological Dysregulation Associated With Frailty in Older Women: Implications for Etiology and Treatment,” Journals of Gerontology Series A‐Biological Sciences & Medical Sciences 64, no. 10 (2009): 1049–1057.
S. Sundermann, A. Dademasch, A. Rastan, et al., “One‐Year Follow‐Up of Patients Undergoing Elective Cardiac Surgery Assessed With the Comprehensive Assessment of Frailty Test and its Simplified Form,” Interactive Cardiovascular & Thoracic Surgery 13, no. 2 (2011): 119–123; discussion 123.
A. Venado, C. McCulloch, J. R. Greenland, et al., “Frailty Trajectories in Adult Lung Transplantation: A Cohort Study,” Journal of Heart and Lung Transplantation 38, no. 7 (2019): 699–707.
M. E. Wilson, A. P. Vakil, P. Kandel, C. Undavalli, S. M. Dunlay, and C. C. Kennedy, “Pretransplant Frailty Is Associated With Decreased Survival After Lung Transplantation,” Journal of Heart and Lung Transplantation 35, no. 2 (2016): 173–178.
B. J. Buta, J. D. Walston, J. G. Godino, et al., “Frailty Assessment Instruments: Systematic Characterization of the Uses and Contexts of Highly‐Cited Instruments,” Ageing Research Reviews 26 (2016): 53–61.
S. R. Jha, M. K. Hannu, K. Gore, et al., “Cognitive Impairment Improves the Predictive Validity of Physical Frailty for Mortality in Patients With Advanced Heart Failure Referred for Heart Transplantation,” Journal of Heart and Lung Transplantation 35, no. 9 (2016): 1092–1100.
L. M. Fuller, B. Button, B. Tarrant, et al., “Longer Versus Shorter Duration of Supervised Rehabilitation After Lung Transplantation: A Randomized Trial,” Archives of Physical Medicine and Rehabilitation 98, no. 2 (2016): 220–226.e3.
G. D. Reinsma, N. H. ten Hacken, R. G. Grevink, W. van der Bij, G. H. Koëter, and E. van Weert, “Limiting Factors of Exercise Performance 1 Year After Lung Transplantation,” Journal of Heart & Lung Transplantation 25, no. 11 (2006): 1310–1316.
L. D. Snyder and L. G. Singer, “Beyond the Eyeball Test: Measures of Frailty in Lung Transplantation,” Journal of Heart and Lung Transplantation 38, no. 7 (2019): 708–709, https://doi.org/10.1016/j.healun.2019.05.003.
L. M. Fuller, et al., “Effect of Upper Limb Rehabilitation Compared to No Upper Limb Rehabilitation in Lung Transplant Recipients: A Randomized Controlled Trial,” Archives of Physical Medicine and Rehabilitation 99, no. 7 (2018): 1257–1264.
M. L. Pollock, et al., “ACSM Position Stand: The Recommended Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory and Muscular Fitness, and Flexibility in Healthy Adults,” Medicine & Science in Sports & Exercise 30, no. 6 (1998): 975–991.
D. B. Rolfson, S. R. Majumdar, R. T. Tsuyuki, A. Tahir, and K. Rockwood, “Validity and Reliability of the Edmonton Frail Scale,” Age & Ageing 35, no. 5 (2006): 526–529.
S. G. Haidar, D. Kumar, R. S. Bassi, and S. C. Deshmukh, “Average Versus Maximum Grip Strength: Which Is More Consistent?” Journal of Hand Surgery—British Volume 29, no. 1 (2004): 82–84.
V. Mathiowetz, N. Kashman, G. Volland, K. Weber, M. Dowe, and S. Rogers, “Grip and Pinch Strength: Normative Data for Adults,” Archives of Physical Medicine & Rehabilitation 66, no. 2 (1985): 69–74.
A. S. Zigmond and R. P. Snaith, “The Hospital Anxiety and Depression Scale,” Acta Psychiatrica Scandinavica 67, no. 6 (1983): 361–370.
R. P. Snaith and R. P. Snaith, “The Hospital Anxiety and Depression Scale,” Health & Quality of Life Outcomes 1 (2003): 29.
“The Predictive Value of the Six‐Minute Walk Test and Lung Transplant Survival,” Cardiopulmonary Physical Therapy Journal 17, no. 4 (2006): 143.
A. E. Holland, M. A. Spruit, T. Troosters, et al., “An Official European Respiratory Society/American Thoracic Society Technical Standard: Field Walking Tests in Chronic Respiratory Disease,” European Respiratory Journal 44, no. 6 (2014): 1428–1446, https://doi.org/10.1183/09031936.00150314.
J. P. Singer, J. M. Diamond, C. J. Gries, et al., “Frailty Phenotypes, Disability, and Outcomes in Adult Candidates for Lung Transplantation,” American Journal of Respiratory and Critical Care Medicine 192, no. 11 (2015): 1325–1334.
S. R. Jha, M. Hannu, P. Newton, et al., “Frailty as a Predictor of Outcomes in Heart Transplant‐Eligible Patients With Advanced Heart Failure,” The Journal of Heart and Lung Transplantation 34, no. 4 (2015): S187–S188.
L. M. Fuller, B. Button, B. Tarrant, et al., “Patients' Expectations and Experiences of Rehabilitation Following Lung Transplantation,” Clinical Transplantation 28, no. 2 (2014): 252–258.
C. de Labra, C. Guimaraes‐Pinheiro, A. Maseda, T. Lorenzo, and J. C. Millán‐Calenti, “Effects of Physical Exercise Interventions in Frail Older Adults: A Systematic Review of Randomized Controlled Trials,” BMC Geriatrics 15 (2015): 154, https://doi.org/10.1186/s12877‐015‐0155‐4.
J. P. Singer, J. D. Christie, J. M. Diamond, et al., “Development of the Lung Transplant Frailty Scale (LT‐FS),” The Journal of Heart and Lung Transplantation 42, no. 7 (2023): 892–904, https://doi.org/10.1016/j.healun.2023.02.006.

Auteurs

Louise Mary Fuller (LM)

Physiotherapy Department, The Alfred Hospital, Melbourne, Victoria, Australia.
Respiratory Department, Lung Transplant, The Alfred Hospital, Melbourne, Victoria, Australia.
Department of Physiotherapy, Swinburne University, Hawthorn, Victoria, Australia.

Helen M Whitford (HM)

Respiratory Department, Lung Transplant, The Alfred Hospital, Melbourne, Victoria, Australia.

Rebecca Robinson (R)

Physiotherapy Department, The Alfred Hospital, Melbourne, Victoria, Australia.

Yvie Cristiano (Y)

Respiratory Department, Lung Transplant, The Alfred Hospital, Melbourne, Victoria, Australia.

Ranjana Steward (R)

Physiotherapy Department, The Alfred Hospital, Melbourne, Victoria, Australia.

Megan Poulsen (M)

Physiotherapy Department, The Alfred Hospital, Melbourne, Victoria, Australia.

Eldho Paul (E)

Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
The Alfred Hospital, Melbourne, Victoria, Australia.

Greg Snell (G)

Respiratory Department, Lung Transplant, The Alfred Hospital, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH